Home › Companies › AMICUS THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and AMICUS THERAPEUTICS INC.’s Form 8-K, filed 2024-06-07 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AMICUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AMICUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-07 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Eiry W. Roberts | 248,107,021 | -- | -- | 6,738,791 | 11,256,697 | Majority: yes |
| Elect Director: Craig A. Wheeler | 248,172,753 | -- | -- | 6,673,059 | 11,256,697 | Majority: yes |
| Elect Director: Burke W. Whitman | 245,493,258 | -- | -- | 9,352,554 | 11,256,697 | Majority: yes |
| Proposal 2: Approval of the Amended and Restated 2007 Equity Incentive Plan. | 245,475,071 | 9,101,663 | 269,078 | -- | 11,256,697 | Majority: yes |
| Proposal 3: Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023. | 258,841,833 | 7,207,672 | 53,004 | -- | -- | Majority: yes |
| Proposal 4: Approval, on an advisory basis, of the Company's executive compensation. | 246,376,429 | 6,826,611 | 1,642,772 | -- | 11,256,697 | Majority: yes |
Source: AMICUS THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-07 — read the filing on EDGAR.
Each item below shows how the 259 asset managers that disclosed a AMICUS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AMICUS THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 12 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 4: Approval, on an advisory basis, of the Company's executive compensation.”): 246,376,429 for, 6,826,611 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 252 asset managers below cast 99% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,997,826 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 24,486,334 | 0 | 0 | 0 | For |
| BlackRock | 20,885,495 | 0 | 0 | 0 | For |
| State Street | 17,885,885 | 0 | 0 | 0 | For |
| Wellington | 17,470,228 | 0 | 0 | 0 | For |
| Janus Henderson | 13,166,124 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 12,378,803 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,848,699 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 9,742,127 | 0 | 0 | 0 | For |
| Fidelity | 9,452,673 | 0 | 0 | 0 | For |
| American Century | 9,180,758 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 9,029,842 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 6,271,445 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,197,159 | 0 | 0 | 0 | For |
| Invesco | 5,932,177 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| Fiera Capital Corp | 4,704,442 | 0 | 0 | 0 | For |
| Charles Schwab | 4,663,768 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 4,600,894 | 0 | 0 | 0 | For |
| Victory Capital | 3,777,450 | 0 | 0 | 0 | For |
| Northern Trust | 2,950,072 | 196 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,557,543 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,502,893 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
Showing the 25 largest of 252 asset managers. See all 252 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Approval of the Amended and Restated 2007 Equity Incentive Plan.”): 245,475,071 for, 9,101,663 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 78 asset managers below cast 96% of the shares they voted on this item FOR (129,030,390 for, 4,912,764 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 9,029,842 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,449 | 1,036 | 0 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 0 | 4,724,247 | 0 | 0 | Against |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 998,547 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 537,137 | 76,652 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 499,068 | 77,196 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023.”): 258,841,833 for, 7,207,672 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 75 asset managers below cast 99.4% of the shares they voted on this item FOR (123,785,001 for, 627,360 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,449 | 1,036 | 0 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 998,547 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 604,402 | 0 | 0 | Against |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Burke W. Whitman”): 245,493,258 for, 9,352,554 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 72 asset managers below cast 100% of the shares they voted on this item FOR (119,625,238 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,081 | 0 | 1,404 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 2,909,268 | 0 | Abstain |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 998,547 | 0 | Abstain |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 446,111 | 0 | 316,459 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Craig A. Wheeler”): 248,172,753 for, 6,673,059 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 72 asset managers below cast 100% of the shares they voted on this item FOR (122,862,189 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,815 | 0 | 670 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 998,547 | 0 | Abstain |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Eiry W. Roberts”): 248,107,021 for, 6,738,791 withheld, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 72 asset managers below cast 100% of the shares they voted on this item FOR (122,862,189 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,815 | 0 | 670 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 998,547 | 0 | Abstain |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.
97% Majority: yes · of votes cast
AMICUS THERAPEUTICS INC.’s own tally for this item (“Proposal 4: Approval, on an advisory basis, of the Company's executive compensation.”): 246,376,429 for, 6,826,611 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 4 asset managers below cast 99.9% of the shares they voted on this item FOR (16,174,029 for, 600 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 13,658,658 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 2,500,000 | 0 | 0 | 0 | For |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 15,371 | 0 | 0 | 0 | For |
| Sarasin & Partners LLP | 0 | 600 | 0 | 0 | Against |
Ranked by the number of AMICUS THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 41,997,826 |
| 2 | PERCEPTIVE ADVISORS LLC | 24,486,334 |
| 3 | BlackRock | 20,885,495 |
| 4 | State Street | 17,885,885 |
| 5 | Wellington | 17,470,228 |
| 6 | Janus Henderson | 13,166,124 |
| 7 | Redmile Group, LLC | 12,378,803 |
| 8 | JANUS INVESTMENT FUND | 9,913,817 |
| 9 | JPMorgan | 9,848,699 |
| 10 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 9,742,127 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to AMICUS THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AMICUS THERAPEUTICS INC.'s shareholder meeting held 2024-06-06, in the 2023-2024 proxy season, 259 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,867 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, THE COMPANY'S EXECUTIVE COMPENSATION. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AMICUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-07.
AMICUS THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.